Michael David Smith, Senior VP, Development at KalVista Pharmaceuticals, Inc. (KALV), sold 20,028 shares at $25.76 ($516K) on 2021-04-28, disclosed to the SEC on 2021-04-30.
Open-market sale of $516k KALV by Senior VP, Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.76 | 10,014 | $258K | 50.0% |
| 2 | $25.76 | 10,014 | $258K | 50.0% |
| Total | $25.76 avg | 20,028 | $516K | 100% |